Of Interest

Data from RELATIVITY-047 show consistent benefits with nivolumab/relatlimab across most patient subgroups, including those with BRAF-mutated disease.

While many people are familiar with skin melanoma, this type of cancer can also happen in the eye. Though rare, ocular melanoma can be deadly if tumor cells spread from the eye to other organs.

Melanoma is one of the most aggressive skin cancers, with over 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly. However, early detection and advanced treatments can significantly improve survival rates. Researchers at Kaunas University of Technology (KTU) are contributing to the development of a non-invasive melanoma treatment, using light and special dyes.

During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in metastatic melanoma and when to stop therapy.